BioAlert Solutions Inc., a provider of automated water pathogen detection solutions, announced the successful close of a $2.5M investment round co-led by GreenSky Ventures’ Fund VI and Cycle H2O Fund I, with participation from Spring Ventures and Fondaction. This strategic funding will enable BioAlert to accelerate its expansion across North America, strengthen its distribution network, and advance the next generation of its detection platform.
BioAlert’s flagship solution delivers rapid, on-site detection of pathogens—notably Legionella—using a fully automated, cartridge-based platform that integrates IoT technology and proprietary software. Unlike traditional laboratory testing methods that take up to two weeks, BioAlert’s system delivers quantitative Polymerase Chain Reaction (qPCR)-based results within hours and without requiring manual intervention or specialized personnel.
“This is a pivotal moment for BioAlert,” said Étienne Lemieux, CEO and Co-Founder of BioAlert Solutions. “As demand for faster, smarter and more automated water safety tools continues to grow, this funding empowers us to meet that demand head-on. With support from GreenSky and our strategic partners, we’re scaling our impact—helping facilities worldwide optimize water treatment, reduce risk, and stay ahead of evolving regulations.”
BioAlert’s platform is designed for many types of facilities with complex water systems, such as cooling towers and domestic water loops. The system automates both sampling and analysis on-site, enabling real-time monitoring, early intervention, and improved compliance with health and safety regulations. The company’s consumable-based business model also provides a strong foundation for recurring revenue and operational scalability.
“BioAlert offers a timely and transformative solution in an increasingly regulated and risk-sensitive industry,” said Moien Giashi, Principal at GreenSky Ventures. “BioAlert’s platform enhances operational efficiency and provides a clear ROI for customers managing critical water systems.”
“BioAlert’s automated pathogen monitoring system minimizes Legionella risks while reducing costs,” said Michael List, Founder and Managing Partner of GreenSky Ventures. “The company is poised to set the standard for real-time water quality monitoring, which will become increasingly important as regulations expand across jurisdictions. BioAlert’s strong traction, recurring revenue, and industry partnerships demonstrate the company’s valuable position in the market. GreenSky is excited to support BioAlert’s growth in delivering safer, more efficient water management solutions.”
The new funding will scale manufacturing capacity, further build distribution partnerships across North America, and accelerate R&D for BioAlert’s second-generation system. The company is also preparing to expand its testing capabilities to include additional pathogens with applications in food production, pharmaceuticals, and industrial processing.
“Reliable water safety data should be immediate and actionable,” said Dominic Carrier, COO and Co-Founder. “We aim to bring the same level of automation and intelligence to pathogen detection that other industries have adopted in recent years, and to help reduce water and chemical consumption.”
With a growing customer base across North America and Europe, as well as strong tailwinds from regulatory shifts, BioAlert is poised to lead the transformation of water safety management.
About GreenSky Ventures:
GreenSky Ventures is a Toronto-based venture capital firm investing in early-stage Canadian technology startups. Through its affiliated GreenSky Accelerator Funds I–VI, the firm provides capital and strategic guidance to high-growth potential companies. Learn more at greensky.vc.
About BioAlert
BioAlert Solutions has developed an automated water quality monitoring system designed to control the proliferation of pathogens in water. The company’s device runs on-site quantitative polymerase chain reaction (qPCR) tests to identify pathogens of concern, sending alarm signals to the designated personnel if levels deviate from safe baseline levels. This fully automated monitoring system reduces labour costs, minimizes human error, and provides a reliable and accurate solution to ensure businesses can take timely action to prevent disease outbreaks. For more information on the company, visit https://www.bioalert.ca/
About Cycle H2O
Cycle H2O is an early-stage VC fund managed by Cycle Capital and H2O Innovation.. Uniquely focused on investing in water tech startups in Canada and the US, the fund aims to support the growth of innovative solutions to protect, conserve and better utilize the water resource in the industrial, agriculture and municipal sectors. For more information visit https://cyclecapital.com.
